↓ Skip to main content

Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary Disease

Overview of attention for article published in PharmacoEconomics, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
77 Mendeley
Title
Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary Disease
Published in
PharmacoEconomics, February 2015
DOI 10.1007/s40273-015-0252-4
Pubmed ID
Authors

Kunal Srivastava, Deepika Thakur, Sheetal Sharma, Yogesh Suresh Punekar

Abstract

An understanding of the humanistic and economic burden of individuals with symptomatic chronic obstructive pulmonary disease (COPD) is required to inform payers and healthcare professionals about the disease burden.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 76 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 19%
Student > Master 13 17%
Student > Ph. D. Student 10 13%
Student > Bachelor 10 13%
Student > Doctoral Student 3 4%
Other 12 16%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 22 29%
Nursing and Health Professions 11 14%
Engineering 5 6%
Agricultural and Biological Sciences 4 5%
Economics, Econometrics and Finance 4 5%
Other 13 17%
Unknown 18 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2022.
All research outputs
#2,408,230
of 23,322,966 outputs
Outputs from PharmacoEconomics
#207
of 1,877 outputs
Outputs of similar age
#36,104
of 355,186 outputs
Outputs of similar age from PharmacoEconomics
#4
of 21 outputs
Altmetric has tracked 23,322,966 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,877 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,186 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.